Role of Carbonic Anhydrase in Cerebral Ischemia and Carbonic Anhydrase Inhibitors as Putative Protective Agents

Ischemic stroke is a leading cause of death and disability worldwide. The only pharmacological treatment available to date for cerebral ischemia is tissue plasminogen activator (t-PA) and the search for successful therapeutic strategies still remains a major challenge. The loss of cerebral blood flo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulli, Irene, Dettori, Ilaria, Coppi, Elisabetta, Cherchi, Federica, Venturini, Martina, Di Cesare Mannelli, Lorenzo, Ghelardini, Carla, Nocentini, Alessio, Supuran, Claudiu T., Pugliese, Anna Maria, Pedata, Felicita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126098/
https://www.ncbi.nlm.nih.gov/pubmed/34068564
http://dx.doi.org/10.3390/ijms22095029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126098/
https://www.ncbi.nlm.nih.gov/pubmed/34068564
http://dx.doi.org/10.3390/ijms22095029

Ejemplares similares